Liven Pharma (KAR:LIVEN) EV-to-EBITDA: (As of Sep. 03, 2026)

Name: Liven Pharma Ltd (LIVEN) — Historical Annual & Quarterly Data
Creator: GuruFocus
License: https://www.gurufocus.com/terms-of-service.php

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Liven Pharma Ltd KAR:LIVEN

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Liven Pharma EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Liven Pharma's enterprise value is ₨3,763.11 Mil. Liven Pharma does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Liven Pharma's EV-to-EBITDA at this moment.

The historical rank and industry rank for Liven Pharma's EV-to-EBITDA or its related term are showing as below:

KAR:LIVEN's EV-to-EBITDA is not ranked ^*
in the Manufacturing - Apparel & Accessories industry.
Industry Median: 9.14
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-09-03), Liven Pharma's stock price is ₨33.29. Liven Pharma does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Liven Pharma's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Liven Pharma (KAR:LIVEN) EV-to-EBITDA Explanation

Liven Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	33.29	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Liven Pharma EV-to-EBITDA Related Terms

Liven Pharma EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Liven Pharma's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Liven Pharma EV-to-EBITDA Chart

Liven Pharma Annual Data

Trend

EV-to-EBITDA

Liven Pharma Semi-Annual Data

EV-to-EBITDA

Liven Pharma EV-to-EBITDA Competitor Comparison

For the Textile Manufacturing subindustry, Liven Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Liven Pharma EV-to-EBITDA vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Liven Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Liven Pharma's EV-to-EBITDA falls into.

Save Embed